Consistent with prior reports of procognitive effects of NAAG peptidase inhibition [7, 8, 11], 2-PMPA significantly improved performance on this task in the 9-month old triple mutant Alzheimer’s disease mice. This evidence concerns the gene LAP3 and early-onset autosomal dominant Alzheimer disease.